Noncommunicable Diseases in the Developing World Addressing Gaps in Global Policy and Research

Presents a framework for understanding the salience of specific policy recommendations and detailed steps that can be taken now to move forward in the global campaign against NCDs. (Public Health)

Über den Autor / die Autorin

Louis Galambos is a professor of history at Johns Hopkins University and co-director of the Institute for Applied Economics, Global Health, and the Study of Business Enterprise.Jeffrey L. Sturchio is senior partner at Rabin Martin, a visiting scholar at the Johns Hopkins Institute for Applied Economics, Global Health, and the Study of Business Enterprise, and former president and CEO of the Global Health Council.

Produktdetails

• Autoren: Louis Galambos, Louis (EDT)/ Sturchio Galambos, Louis Sturchio Galambos, Louis (The Johns Hopkins University) Stu Galambos
• Mitarbeit: Louis Galambos (Herausgeber), Jeffrey L Sturchio (Herausgeber), Jeffrey L. (Senior Partner Sturchio (Herausgeber), Jeffrey L. Sturchio (Herausgeber), Louis (The Johns Hopkins University) Galambos (Herausgeber)
• Verlag: Johns Hopkins University Press
• Inhalt: Buch
• Produktform: Taschenbuch
• Erscheinungsdatum: 10.01.2014
• Thema: Sozialwissenschaften, Recht,Wirtschaft > Politikwissenschaft > Politische Wissenschaft und Politische Bildung; Naturwissenschaften, Medizin, Informatik, Technik > Medizin > Allgemeines
• EAN: 9781421412924
• ISBN: 978-1-4214-1292-4
• Anzahl Seiten: 184
• Themen: MEDICAL / Diseases, MEDICAL / Public Health, MEDICAL / Preventive Medicine, POLITICAL SCIENCE / Public Affairs & Administration, Diseases & disorders, Public Administration, Public health & preventive medicine, Diseases and disorders, Public health and preventive medicine, Public Health & Safety Law, Public health and safety law, Public administration / Public policy, LAW / Health & Safety, NCD;chronic disease;global health policy;health system strengthening;health disparities;health inequalities;supply chain management;regulatory harmonization;drug regulatory affairs;multisectoral action in health;global burden of disease;public-privat